The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving care at 1 of 4 pediatric SCD clinics.
The main question\[s\]it aims to answer are:
* Does SCThrive improve patient activation? * Does SCThrive improve self-management behaviors, daily functioning, and decrease emergency room visits? * Are any improvements maintained 3 months after treatment?
Participants will complete self-management related surveys before, after, and 3 months following their participation in an 8- week, virtual group intervention with an accompanying mobile app (SCThrive).
Researchers will compare outcomes for participants who receive SCThrive and participants who receive uniform standard care (SCHealthED which = standard of care plus SCD educational text messages) to see if there are differences in patient activation, self-management behaviors, daily functioning, and emergency room visits.
Patient of a participating SCD Clinic
Confirmed diagnosis of SCD
13-21 years of age
Another chronic disease (which would complicate measurement of patient activation)
Non-English-speaking
Cognitive or psychiatric disorder that the physician or study therapists believe would impair study participation.
Children's Hospital Medical Center, Cincinnati
Lead sponsor
Nemours Children's Health System
Collaborator
Emory University
Collaborator
Children's Hospital of Philadelphia
Collaborator